Cardiovascular risk assessment

J. Ferrieres

首页> 外文期刊>Archives of cardiovascular diseases. Supplements >Cardiovascular risk assessment

【24h】

Cardiovascular risk assessment

机译：心血管风险评估

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Cardiovascular risk is a fundamental issue. The risk concept was born a long time ago within health insurance companies in order to predict diseases and death. The concept of risk factors first appeared in 1961 through the landmark Framingham study. Models were quite simple at the beginning, and have since been refined through complex statistical modelling and increased numbers of cohorts. The Framingham Coronary Heart Disease Risk Score and the SCORE risk charts remain the two leading formulae. However, many other tools exist and are used, such as the PROCAM, ASSIGN, QRISK and Reynolds algorithms. Caution is the rule if these formulae are applied to other populations, or in other places, or in another time period. International and national guidelines do recommend cardiovascular risk evaluation with such scores and high-risk categories must be treated first. Evidence from future randomized controlled trials combined with the global economy may modify our current practice.

机译：心血管风险是一个基本问题。风险概念早在很久以前就诞生于健康保险公司中，以预测疾病和死亡。危险因素的概念最早是在1961年通过具有里程碑意义的Framingham研究出现的。模型从一开始就非常简单，并且此后通过复杂的统计模型和同类群组的数量进行了完善。 Framingham冠心病风险评分和SCORE风险表仍然是两个主要公式。但是，存在并使用了许多其他工具，例如PROCAM，ASSIGN，QRISK和Reynolds算法。如果将这些公式应用于其他人群，其他地方或其他时间段，则应谨慎行事。国际和国家指南确实建议对具有此类评分的心血管疾病风险评估，必须首先处理高风险类别。未来随机对照试验与全球经济相结合的证据可能会改变我们目前的做法。

著录项

来源
《Archives of cardiovascular diseases. Supplements》 |2012年第4期|共11页
作者
J. Ferrieres;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 fre
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Large Scale Analysis of Lifetime Risk of Cardiovascular Disease in Europe and Population Attributable Risk of Cardiovascular Risk Factors for the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Investigators [J] . Blankenberg Stefan Circulation: An Official Journal of the American Heart Association . 2016,第25期

机译：欧洲心血管疾病终生风险的大规模分析和欧洲心血管风险评估生物标志物的生物标志物人群归因于心血管疾病危险因素的风险（BiomarCaRE）研究者
2. Cardiovascular risk assessments in chronic myeloid leukemia allow identification of patients at high risk of cardiovascular events during treatment with nilotinib [J] . Breccia Massimo, Colafigli Gioia, Molica Matteo, American Journal of Hematology . 2015,第5期

机译：慢性髓细胞性白血病的心血管风险评估可确定尼洛替尼治疗期间发生心血管事件高风险的患者
3. Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: Substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) [J] . Bohm M, Baumhakel M, Probstfield JL, The American heart journal . 2007,第1期

机译：心血管高危患者的性功能，满意度以及勃起功能障碍与心血管疾病和危险因素的关联：正在进行中的替米沙坦单独研究以及与雷米普利全球终点试验/替米沙坦的随机评估研究相结合，用于ACE耐受的心血管疾病患者（目标/超越）
4. Cardiovascular event risk assessment — Fusion of individual risk assessment tools applied to the Portuguese population [C] . Paredes S., Rocha T., de Carvalho P., International Conference on Information Fusion;FUSION 2012 . 2012

机译：心血管事件风险评估—融合了适用于葡萄牙人口的个体风险评估工具
5. Cardiovascular risk factors among college students: Knowledge, perception and risk assessment. [D] . Tran, Dieu-My T. 2014

机译：大学生中的心血管危险因素：知识，知觉和风险评估。
6. The Role of Cardiovascular Risk Assessment in Preventive Medicine: A Perspective from Portugal Primary Health-Care Cardiovascular Risk Assessment [O] . Paulo Santos 2020

机译：心血管风险评估在预防医学中的作用：葡萄牙初级卫生保健心血管风险评估的视角
7. P1246Age-, body size-, and sex-specific reference values for tricuspid valve apparatus parameters by real-time three-dimensional transthoracic echocardiographyP1247Surgical therapy in infective endocarditis: predisposing and prognostic factorsP1248Evalutation of MV annulus geometry modifications before and after mitraclip implantation with 3D transesophageal echocardiographyP1249Prognostic echocardiographic parameters for successful transcatheter edge-to-edge mitral valve repairP1250Influence of body surface area in diagnosis and outcome patient-prosthesis mismatch after TAVI. Is it necessary to adjust for ideal body weight?P1251Outcome of paradoxical low-flow low-gradient severe AS following TAVI: paradoxical VS parallel to outcome of high gradient ASP1252Prognostic role of cardiac calcifications in subjects without overt significant heart disease and previous cardiovascular events: is there an additive value over cardiovascular risk factors scores?P1253Aging degeneration of mitral valve without leaflet prolapse or tethering as a cause of severe mitral regurgitationP1254Cardiovascular risk assessment should be performed in patients with incidental aortic sclerosisP1255Cardiac valve calcification score: simple 2D echocardiographic tool for cardiovascular risk stratification in patients with chronic renal failureP1256Diastolic mitral regurgitation following transcatheter aortic valve replacement: prevalence, predictors and impact on outcomesP1257Timing of myocardial shortening determines left ventricular regional remodelling in hearts with conduction delaysP1258Myocardial stiffness assessment using shear wave imaging in healthy children and hypertrophic cardiomyopathyP1259Assessment of right ventricular response to exercise using vector velocity imaging in hypertrophic cardiomyopathyP1260Diagnostic value of cardiac biomarkers (high sensitive troponin T and N-terminal pro-brain natriuretic peptide) in patients with infiltrative cardiomyopathiesP1261Right ventricular global longitudinal strain differentiates between adolescent patients with definite, borderline and possible ARVC and controlsP1262 echogrqphic predictif factors of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasiaP1263Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fractionP1264Chronotropic response in mitochondrial (ANT1) cardiomyopathyP1265 The effect of cardiovascular risk factors and cancer type in anthracycline's cardiotoxicityP1266Revisiting the echocardiographic features of acute myocarditisP1267Altered circulation in fetuses of diabetic mothers: a fetal computational model analysisP1268Increased epicardial adipose tissue is related to stress-induced cardiomyopathyP1269Contrast enhanced ultrasound of kidney perfusion in patients with renal artery stenosis: diagnostic and prognostic applications. [O] . F. Ancona, R. Ilhao Moreira, V. Lavanco, 2016

机译：P1246age-，身体大小和性别特异性参考Tricuspid阀装置参数通过实时三维经线性超声心动图124772777777747774747478EVALIGUTALMEXP1249预期植入前后MV环形植入前后MV环空性修饰。超声心动图参数用于成功的经截管边缘到边缘二尖瓣修复P1250中的体表面积诊断和结果患者假体在Tavi后的不匹配。是否有必要调整理想的体重？P1251矛盾的低流量低梯度严重，如Tavi：矛盾的VS平行于高梯度ASP1252的结果，在没有明显显着的心脏病和以前心血管事件的情况下心脏钙化的促傲作用患有心血管危险因素的添加剂值分数？没有传单脱垂的二尖瓣退化或作为严重二尖瓣血管血管血管病风险评估的患者进行脱垂或系绳，应当在偶然主动脉源肺源P1255Cariac阀钙化评分患者中进行：用于心血管风险分层的简单2D超声心动图工具在慢性肾功能衰竭的患者中，经沟管主动脉瓣膜置换术后：流行率，预测因子和对Otcomasp1257的影响，心肌缩短决定了导通延迟的心中的剩余心室区域重新耦合258MYCIARIAL僵硬评估使用剪切波成像在健康儿童和肥厚性心肌脑病中的舒缓性心脏响应，在渗透心肌肌瘤患者中使用载体速度成像的培养速度成像（高敏感的肌钙蛋白T和N-末端脑Natrietic肽）渗透心肌病，患者心室全局纵向菌株在患有心律失常右心室发育不良患者的心理心律失常患者中的青少年患者与Controlsp1262 echogrqphic预测因子的分歧，患者心血性右心室发育不良患者患者患者患者患者患者患者患者患者患者线粒体（ANT1）心肌病患者的喷射FRACTIONP1264系列响应1265心血管危险因素和癌症类型在蒽丙烯的心肌毒性皮1126660中的影响访问患有糖尿病母亲胎儿胎儿急性心肌炎的超声心动图，患者患者：胎儿计算模型分析P1268增加外膜脂肪组织与肾动脉狭窄患者肾脏灌注的应激诱导的心肌病，增强超声波：诊断和预后应用。
8. Effects of Omega-3 Fatty Acids on Cardiovascular Risk Factors and Intermediate Markers of Cardiovascular Disease. Evidence Report/Technology Assessment No. 93 [R] . Balk, E., Chung, M., Lichtensein, A., 2004

机译：Omega-3脂肪酸对心血管疾病心血管危险因素和中间标志物的影响。第93号证据报告/技术评估

Cardiovascular risk assessment

摘要

著录项

相似文献

相关主题

期刊订阅